Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
Treatments
Posted inNPR
FDA gives thumbs down to MDMA for now, demanding further research
The much-anticipated decision has rattled supporters of psychedelic therapies. The drugmaker says it will ask the agency to reconsider.
Posted inNPR
New blood tests can help diagnose Alzheimer’s. Are doctors ready for what’s next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
Posted inNPR
Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?
Advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA’s advisory committee in June. They face an uphill battle.
Posted inNPR
A scientist took a psychedelic drug — and watched his own brain ‘fall apart’
Scientists scanned the brains of people who took psilocybin, including a member of the research team. The scans showed how the drug disrupts key networks, potentially enhancing brain plasticity.
Posted inNPR
Ozempic’s popularity leads to shortages for people with Type 2 diabetes
Drugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can’t get them when they need them.
Posted inNPR
Doctors try a controversial technique to reduce the transplant organ shortage
Doctors say they can boost the odds donated organs will be usable by restarting blood circulation with a pump after donors are declared dead. Critics say the procedure blurs the definition of death.
Posted inNPR
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA.
Posted inNPR
This new brain-mapping device could make neurosurgery safer
A flexible film bristling with tiny sensors could make surgery safer for patients with a brain tumor or severe epilepsy.
Posted inHealth, Stories
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.